Economic Burden of Veno-occlusive Disease in Patients With B-cell Acute Lymphoblastic Leukemia in the United States

B Cell ◽

Economic Burden ◽

Lymphoblastic Leukemia ◽

The United States ◽

Occlusive Disease ◽

Economic burden associated with adverse events of special interest in patients with relapsed Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in the United States

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1080/14737167.2018.1490645 ◽

2018 ◽

Vol 18 (5) ◽

pp. 573-580

Author(s):

Xinke Zhang ◽

Xue Song ◽

Lorena Lopez-Gonzalez ◽

Krutika Jariwala-Parikh ◽

Ze Cong

Keyword(s):

United States ◽

Adverse Events ◽

B Cell ◽

Economic Burden ◽

Special Interest ◽

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

The United States ◽

Poster: ALL-190: Cost-Effectiveness of KTE-X19 for Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) in the United States

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01297-0 ◽

2021 ◽

Vol 21 ◽

pp. S207

Author(s):

Bijal Shah ◽

Nathaniel Smith ◽

Angie Raad ◽

Chaoling Feng ◽

Gab Castaigne ◽

...

Keyword(s):

United States ◽

Cost Effectiveness ◽

B Cell ◽

Lymphoblastic Leukemia ◽

The United States ◽

Adult Patients ◽

ALL-190: Cost-Effectiveness of KTE-X19 for Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) in the United States

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01658-x ◽

2021 ◽

Vol 21 ◽

pp. S272-S273

Author(s):

Bijal Shah ◽

Nathaniel Smith ◽

Angie Raad ◽

Chaoling Feng ◽

Gab Castaigne ◽

...

Keyword(s):

United States ◽

Cost Effectiveness ◽

B Cell ◽

Lymphoblastic Leukemia ◽

The United States ◽

Adult Patients ◽

PIH35 ECONOMIC BURDEN FOR PEDIATRIC PATIENTS WITH RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN THE US

Value in Health ◽

10.1016/j.jval.2019.04.835 ◽

2019 ◽

Vol 22 ◽

pp. S188

Author(s):

X. Zhang ◽

X. Song ◽

L. Lopez-Gonzalez ◽

K. Jariwala-Parikh ◽

Z. Cong

Keyword(s):

B Cell ◽

Economic Burden ◽

Pediatric Patients ◽

Lymphoblastic Leukemia ◽

The Us ◽

Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States

PharmacoEconomics ◽

10.1007/s40273-019-00812-6 ◽

2019 ◽

Vol 37 (9) ◽

pp. 1177-1193 ◽

Cited By ~ 6

Author(s):

Thomas E. Delea ◽

Xinke Zhang ◽

Jordan Amdahl ◽

Diana Boyko ◽

Franziska Dirnberger ◽

...

Keyword(s):

United States ◽

Cost Effectiveness ◽

B Cell ◽

Lymphoblastic Leukemia ◽

The United States ◽

Adult Patients ◽

Cell Precursor ◽

Inotuzumab Ozogamicin

Incidence and survival of T-cell acute lymphoblastic leukemia in the United States

Leukemia & Lymphoma ◽

10.1080/10428194.2018.1522442 ◽

2018 ◽

Vol 60 (5) ◽

pp. 1171-1178 ◽

Cited By ~ 2

Author(s):

Guru Subramanian Guru Murthy ◽

Satish Kumar Pondaiah ◽

Sameem Abedin ◽

Ehab Atallah

Keyword(s):

United States ◽

T Cell ◽

Lymphoblastic Leukemia ◽

The United States ◽

Blinatumomab Induced Response of Multiply Refractory Multiple Myeloma in the Context of Secondary Pre-B Cell Acute Lymphoblastic Leukemia

Annals of Hematology & Oncology ◽

10.26420/annhematoloncol.2017.1174 ◽

2017 ◽

Vol 4 (10) ◽

Cited By ~ 4

Author(s):

Keith W. Pratz

Keyword(s):

Multiple Myeloma ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Induced Response ◽

Refractory Multiple Myeloma ◽

The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)

Case Medical Research ◽

10.31525/ct1-nct04166838 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

Clinical Study ◽

B Cell ◽

Lymphoblastic Leukemia ◽

Relative expression and prognostic significance of forkhead box P3 in childhood B‐cell acute lymphoblastic leukemia

Pediatric Blood & Cancer ◽

10.1002/pbc.29129 ◽

2021 ◽

Author(s):

Hossam El‐Din A. Abdelhafeez ◽

Fatma F. Abdel Hamid ◽

Naglaa M. Hassan ◽

Magda M. Assem ◽

Ahmed F. Soliman

Keyword(s):

B Cell ◽

Lymphoblastic Leukemia ◽

Prognostic Significance ◽

Forkhead Box P3 ◽

Relative Expression ◽

Forkhead Box ◽

Inherited GATA3 variant associated with positive minimal residual disease in childhood B‐cell acute lymphoblastic leukemia via asparaginase resistance

Clinical and Translational Medicine ◽

10.1002/ctm2.507 ◽

2021 ◽

Vol 11 (8) ◽

Author(s):

Chunjie Li ◽

Wenyi Liang ◽

Yingyi He ◽

Xinying Zhao ◽

Jiabi Qian ◽

...

Keyword(s):

B Cell ◽

Minimal Residual Disease ◽

Residual Disease ◽

Lymphoblastic Leukemia ◽

Cell Acute Lymphoblastic Leukemia ◽

Minimal Residual